Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming
July 24, 2024
The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators
October 12, 2023
Thermo Fisher Scientific said on Tuesday it would acquire Olink Holding AB in a deal valued at $3.1 billion as the U.S. medical equipment maker seeks to boost its life sciences portfolio
April 26, 2024
AbbVie said on Wednesday it would buy Cerevel Therapeutics, a developer of drugs for neurological conditions, for about $8.7 billion in a bid to replace revenue as its arthritis drug
April 26, 2024
Activist investor Carl Icahn said on Monday that he plans to oust directors at Illumina, signalling plans to mount a second board challenge at the gene-sequencing
April 26, 2024
A Washington-based global trade association representing biotechnology companies is taking steps to "separate" from Chinese member Wuxi AppTec, according to a letter from
April 26, 2024
Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche
April 26, 2024
Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan.
May 07, 2024
China has approved the safety of gene-edited wheat for the first time as Beijing cautiously moves forward with commercial growing of genetically modified food crops.
May 22, 2024
A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S.
July 02, 2024
Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the
June 13, 2024
Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' experimental drug for low blood sugar in a $35.1 million deal, Eiger said in a filing on
June 21, 2024
Indian state minister to meet Samsung officials in bid to resolve strike
European shares jump 1% on tech boost; ECB meet in focus
Zimbabwe blueberry farmers chase booming demand but face funding woes
London's FTSE 100 recovers as US rate cut certainty helps sentiment
Pac-12 targeting Boise St., Fresno St., San Diego St., Colorado St. for rebuild, AP sources say
Murdoch succession battle to play out in Nevada courtroom
Reggie Bush was at his LA-area home when 3 male suspects attempted to break in